Download additional tools and resources on pediatric/adolescent obesity.
Download additional tools and resources on pediatric/adolescent obesity.
Download additional tools and resources on pediatric/adolescent obesity.
In the first episode of this CMEOCast podcast series, Dr. Faulk and Dr. Renew will help learners to translate data into clinical practice regarding the differences between clinical assessment, qualitative assessment, and quantitative TOF monitoring and their efficacy in detecting residual neuromuscular blockade.
In the second episode of the CMEOCast podcast series, J.Ross Renew, MD and Dru Riddle, DNP, CRNA will guide learners through strategies to best incorporate recommendations from the 2023 ASA guidelines into clinical practice.
During this 60-minute recorded symposium, expert panelists will discuss GD, including its less commonly reported manifestations, diagnostic pathways, and patient-centric multidisciplinary management of the disorder.
Dr. Jennifer Gordon was diagnosed with EGPA in 2014 and is the Vasculitis Patient Powered Research Network (VPPRN) Co-Principal Investigator and co-Lead Patient-Partner in the EGPA Registry. During this 30-minute CMEO Snack, Dr. Gordon will join Dr. Michael Wechsler, a national expert in EGPA. They will discuss how EGPA impacts patient quality of life and how clinicians can better detect and manage hidden symptoms of disease. Patient perspectives on delayed diagnosis, disease impact on their daily functioning, treatment options, and chronic steroid use will be included in the discussion.
The second episode of this CMEO BriefCase series on narcolepsy focuses on distinguishing narcolepsy from other disorders, with expert faculty demonstrating how to choose, implement, and interpret screening and diagnostic tools.
In this educational webcast, expert faculty will discuss treatment needs of adult patients with SMA and the unique challenges and experiences of those patients transitioning from pediatric to adult care. The webcast will also include insights about how to navigate systems and utilize the most up-to-date and appropriate therapeutic approaches for adult patients with SMA.
